We know that chronic hepatitis B infection can lead to substantial morbidity and mortality. While there is no cure, antiviral treatment, monitoring, and liver cancer surveillance can improve outcomes for people living with hepatitis B. Additionally, effective preventative hepatitis B vaccines are available.
Until recently, guidelines recommended that only people at high risk of infection be screened for hepatitis B virus (HBV). Under that policy, we missed a lot of people: only an estimated 1 in 3 people in the U.S. with hepatitis B are aware they are infected.